Aclarubicin in the treatment of relapsed or resistant acute myelogenous leukaemia: a phase II trial.

Autor: Evensen, S. A., Wisøff, F., Müller, E., Talstad, I., Waage, A., Johansen, L.
Zdroj: European Journal of Haematology; Jun1987 Supplement S47, Vol. 38 Issue S47, p43-47, 5p
Databáze: Complementary Index